Loxo Oncology Inc.
PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6- -DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CAR- BONITRILE
Last updated:
Abstract:
In some embodiments, provided herein is a process for preparing a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, as disclosed herein.
Status:
Application
Type:
Utility
Filling date:
16 Jun 2020
Issue date:
1 Oct 2020